Infection Control News and Research

RSS

Guidelines: Summer camp returns to normal during COVID-19

A new report describes measures to ensure that youth activities can continue safely, based on sound epidemiological and infectious disease guidelines.

13 Sep 2021

Health care unions defending Newsom from recall will want single-payer payback

Should Gavin Newsom survive the Republican-driven attempt to oust him from office, the Democratic governor will face the prospect of paying back supporters who coalesced behind him.

13 Sep 2021

Surgical hubs, new technology key to tackling the growing NHS waiting lists

Local surgical hubs, new technology to speed up diagnosis, and innovative ways of working will help the NHS to tackle growing waiting lists and treat around 30% more patients who need elective care by 2023/24.

8 Sep 2021

NHS to receive an extra £5.4 billion over next six months to support COVID-19 response

The NHS will receive an extra £5.4 billion over the next six months to support its response to COVID-19 and help tackle waiting lists, the Prime Minister and Health and Social Care Secretary Sajid Javid have announced today.

6 Sep 2021

Increased infectivity and immune evasion drive the spread of Delta SARS-CoV-2 variant

Findings suggest infection control measures against variants will need to continue in the post-vaccination era.

6 Sep 2021

Patients who contract SARS-CoV-2 Delta variant more likely to be hospitalized than those with Alpha

Recently, researchers found the risk of being hospitalized was two times higher for people with the Delta variant as compared to those with the Alpha variant.

6 Sep 2021

Double vaccination reduces the risk of Long COVID by almost half

Adults who have received a double vaccination are 49% less likely to have Long COVID should they contract a COVID-19 infection.

2 Sep 2021

Can SARS-CoV-2 be transmitted in the food cold chain?

A new study reports that the risk of transmitting SARS-CoV-2 through such fomites is very low.

30 Aug 2021

COVID-19 hospitalizations 29 times more likely in unvaccinated individuals, CDC study suggests

Getting inoculated against SARS-CoV-2 protects against getting severe COVID-19 or being hospitalized. In a new study by the U.S. Centers for Disease Control and Prevention (CDC), scientists noted that unvaccinated individuals are 29 times more likely to be hospitalized due to COVID-19 than those who were vaccinated.

25 Aug 2021

Study: Majority of hospital-acquired COVID-19 cases were contracted from other patients

The majority of patients who contracted COVID-19 while in the hospital did so from other patients rather than from healthcare workers, concludes a new study from researchers at the University of Cambridge and Addenbrooke's Hospital.

25 Aug 2021

After pandemic ravaged nursing homes, new state laws protect residents

When the coronavirus hit Martha Leland's Connecticut nursing home last year, she and dozens of other residents contracted the disease while the facility was on lockdown. Twenty-eight residents died, including her roommate.

20 Aug 2021

Vaccine quickly reduced COVID-19 infections among health care workers

A UC Davis Health retrospective study published recently in Infection Control and Hospital Epidemiology shows how quickly COVID-19 infections were reduced among health care workers when vaccines were first distributed late last year.

19 Aug 2021

Study suggests Harmony COVID-19 assay is superior to laboratory-based tests

A new study suggests a new coronavirus test developed by scientists from the University of Washington and the Brotman Baty Institute for Precision Medicine produces faster and more sensitive results than conventional PCR tests to measure severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA.

18 Aug 2021

UK survey reveals variations in care provided across the country

Over 600,000 emergency calls to 999 during the first wave of the pandemic were for suspected Covid, with ambulances sent in almost 80% of cases and 43% of patients being conveyed to hospital, a major new survey of UK ambulance services has shown.

18 Aug 2021

New nanobiotechnology shows remarkable ability to battle dangerous fungal infections

They’re roughly the same size as a coronavirus particle, and 1000 times smaller than a human hair, yet newly engineered nanoparticles developed by scientists at the University of South Australia, are punching well above their weight when it comes to treating drug-resistant fungal infections.

17 Aug 2021

More than one in ten COVID-19 patients acquired the virus in a hospital during UK's first wave

More than one in ten COVID-19 patients in 314 UK hospitals caught the infection in hospital during the first pandemic wave say researchers conducting the world's largest study of severe COVID-19.

16 Aug 2021

‘I don’t want to risk my life for a paycheck’: Immunosuppressed people grapple with returning to work

Elizabeth Groenweghe got a kidney transplant 14 years ago. She now takes several medications to prevent her body from rejecting her transplant organ. But these medications also weaken her immune system, putting her at higher risk of becoming seriously ill if she catches covid-19.

13 Aug 2021

Fine aerosols generated during talking, singing may play a major role in SARS-CoV-2 transmission

The coronavirus disease 2019 (COVID-19) has been thought to spread primarily when an infected person coughs or sneezes, but little is known about its transmissibility through activities such as breathing, talking, and singing.

11 Aug 2021

Comparative scoring system suggests possibility of global COVID-19 eradication

The global eradication of COVID-19 is probably feasible, and more so than it is for polio, although considerably less so than it was for smallpox, suggests a comparative score of technical, sociopolitical, and economic factors for all three infections, published in the online journal BMJ Global Health.

10 Aug 2021

Study shows efficacy of Pfizer-BioNTech and Moderna vaccines against SARS-CoV-2 delta variant

Researchers in Singapore have conducted a study showing that the messenger RNA- (mRNA) based coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna are highly effective at protecting against symptomatic and severe disease following infection with the rapidly spreading B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

2 Aug 2021

Infection Control News and Research

Guidelines: Summer camp returns to normal during COVID-19

Health care unions defending Newsom from recall will want single-payer payback

Surgical hubs, new technology key to tackling the growing NHS waiting lists

NHS to receive an extra £5.4 billion over next six months to support COVID-19 response

Increased infectivity and immune evasion drive the spread of Delta SARS-CoV-2 variant

Patients who contract SARS-CoV-2 Delta variant more likely to be hospitalized than those with Alpha

Double vaccination reduces the risk of Long COVID by almost half

Can SARS-CoV-2 be transmitted in the food cold chain?

COVID-19 hospitalizations 29 times more likely in unvaccinated individuals, CDC study suggests

Study: Majority of hospital-acquired COVID-19 cases were contracted from other patients

After pandemic ravaged nursing homes, new state laws protect residents

Vaccine quickly reduced COVID-19 infections among health care workers

Study suggests Harmony COVID-19 assay is superior to laboratory-based tests

UK survey reveals variations in care provided across the country

New nanobiotechnology shows remarkable ability to battle dangerous fungal infections

More than one in ten COVID-19 patients acquired the virus in a hospital during UK's first wave

‘I don’t want to risk my life for a paycheck’: Immunosuppressed people grapple with returning to work

Fine aerosols generated during talking, singing may play a major role in SARS-CoV-2 transmission

Comparative scoring system suggests possibility of global COVID-19 eradication

Study shows efficacy of Pfizer-BioNTech and Moderna vaccines against SARS-CoV-2 delta variant

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News